Status:
COMPLETED
Anabolic Steroids and Exercise in Hemodialysis Patients
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
End-Stage Renal Disease
Muscle Weakness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a study to find out whether an exercise program during dialysis or a drug called nandrolone decanoate can increase muscle size and strenght in patients on dialysis.
Detailed Description
Dialysis patients have limited physical functioning as measured by self-reported functioning, peak oxygen consumption, physical performance tests, and tests of muscle strength. A recent study highligh...
Eligibility Criteria
Inclusion
- end-stage renal disease on hemodialysis for 3 or more months
Exclusion
- inadequate dialysis; Kt/V \<1.2
- nonadherent to dialysis treatments; missing \>2 dialysis sessions in the month prior to screening
- catabolic state; HIV with opportunistic infection in the last 3 months, malignancy, or infection requiring intravenous antibiotics within 2 months prior to screening
- unable to give informed consent
- active intravenous drug use
- contraindications to resistance exercise; myocardial infarction within 6 months, active angina, uncompensated congestive heart failure, orthopedic or musculoskeletal limitations
Key Trial Info
Start Date :
March 1 2000
Trial Type :
INTERVENTIONAL
End Date :
October 1 2004
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00250536
Start Date
March 1 2000
End Date
October 1 2004
Last Update
January 14 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.